Latest Earnings Growth News

Infragreen launches a strategic review revealing a $10 million on-market buyback and potential asset sales to address significant undervaluation despite strong FY26 growth forecasts.

Peet Limited has upgraded its FY26 net profit guidance by up to 17%, driven by accelerated construction and robust market demand in Western Australia and Queensland.

Australian Clinical Labs appoints Greg Horan as Group CEO effective August 2026, marking a leadership transition after a decade under Melinda McGrath. Horan’s healthcare and operational expertise positions ACL for its next growth phase.

SHAPE Australia has agreed to acquire Australian Professional Shopfitters (APS) for up to $29.4 million, adding a vertically integrated retail fitout capability and boosting earnings with a 5-7% EPS accretion forecast in the first full year.

Promisia Healthcare reported a robust 29% increase in operating revenue for FY26, alongside a new dividend policy tied to operating free cash flow, setting the stage for continued growth in FY27.

Fonterra’s FY26 Q3 results show a $1.8 billion operating profit, up $103 million year-on-year, prompting an uplift and narrowing of earnings guidance. The co-op also announced a stable 2026/27 Farmgate Milk Price forecast amid rising milk collections and ongoing geopolitical risks.

Nufarm Limited posted a 35% rise in underlying net profit after tax to $52.1 million for HY26, driven by margin expansion and cost discipline despite a 5% revenue decline to $1.71 billion. The company confirmed its FY26 outlook, targeting strong earnings growth and leverage reduction.

Kogan.com Ltd reports robust sales and earnings growth for 10 months to April 2026, driven by Kogan.com’s expanding customer base and platform sales, while Mighty Ape shows marked margin improvement amid a strategic pivot.

Challenger Limited unveiled a strategic blueprint at its 2026 Investor Day, leveraging demographic shifts and regulatory reforms to cement its leadership in Australia’s retirement income sector.

Goodman NZ surged to a $248 million statutory profit in FY26, propelled by strong property revaluations and leasing gains, while advancing major development projects and transitioning to a stapled group structure.

Ryman Healthcare reported a substantial reduction in net loss for FY26 alongside its first positive free cash flow in over a decade, driven by operational improvements, refinancing, and land divestments.

Infragreen Group Limited (ASX: IFN) forecasts a robust FY26 with underlying EBITDA rising to $22.5m-$25m and underlying NPAT surging over 270%, driven by solid performances in Energybuild and Pure Environmental. The company anticipates continued momentum into FY27, despite some short-term headwinds in Minemet and Merredin Energy.